Bayesian Capital Management’s ADMA Biologics ADMA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-15,615
| Closed | -$175K | – | 648 |
|
|
2024
Q2 | $175K | Buy |
+15,615
| New | +$175K | 0.02% | 619 |
|
|
2024
Q1 | – | Sell |
-57,915
| Closed | -$262K | – | 754 |
|
|
2023
Q4 | $262K | Sell |
57,915
-18,185
| -24% | -$82.2K | 0.03% | 543 |
|
|
2023
Q3 | $272K | Buy |
+76,100
| New | +$272K | 0.03% | 491 |
|
|
2023
Q2 | – | Sell |
-11,146
| Closed | -$36.9K | – | 755 |
|
|
2023
Q1 | $36.9K | Sell |
11,146
-30,854
| -73% | -$102K | ﹤0.01% | 721 |
|
|
2022
Q4 | $163K | Buy |
+42,000
| New | +$163K | 0.02% | 622 |
|
|
2022
Q3 | – | Sell |
-55,300
| Closed | -$109K | – | 670 |
|
|
2022
Q2 | $109K | Buy |
+55,300
| New | +$109K | 0.02% | 680 |
|